Market capitalization | $483.56m |
Enterprise Value | $476.21m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 34.16 |
EV/Sales (TTM) EV/Sales | 2.03 |
P/S ratio (TTM) P/S ratio | 2.07 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 43.07% |
Revenue (TTM) Revenue | $234.01m |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
9 Analysts have issued a LifeMD forecast:
9 Analysts have issued a LifeMD forecast:
Mar '25 |
+/-
%
|
||
Revenue | 234 234 |
43%
43%
|
|
Gross Profit | 194 194 |
43%
43%
|
|
EBITDA | 2.62 2.62 |
125%
125%
|
EBIT (Operating Income) EBIT | -7.43 -7.43 |
58%
58%
|
Net Profit | -11 -11 |
54%
54%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.
Head office | United States |
CEO | Justin Schreiber |
Employees | 336 |
Founded | 1987 |
Website | www.lifemd.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.